BG Q2 Earnings Beat, Revenues Down Y/Y on Weak Results Across Segments

Bunge Global SA (BG) reported mixed Q2 2025 results, with adjusted EPS of $1.31 beating consensus estimates but falling 24.3% year-over-year, and net sales of $12.8 billion surpassing estimates despite a 3.6% year-over-year decline. The adjusted segment profit dropped 28% due to broad weakness across its Agribusiness, Refined & Specialty Oils, and Milling units. Despite these operational headwinds, the company maintained its previously stated 2025 adjusted EPS guidance of $7.75, which excludes the ongoing integration of its recently completed Viterra acquisition.

Analysis

Bunge Global's (BG) second-quarter 2025 results presented a mixed financial picture, characterized by headline beats on lowered expectations against a backdrop of significant underlying operational weakness. The company surpassed consensus estimates with adjusted EPS of $1.31 and revenue of $12.8 billion, yet these figures represent substantial year-over-year declines of 24.3% and 3.6%, respectively. The core issue lies in profitability, where adjusted total segment operating profit fell 28% and the corresponding margin contracted by 80 basis points to 2.3%. This deterioration was broad-based, with the crucial Agribusiness segment seeing a 22% drop in adjusted profit, Refined & Specialty Oils plunging 40%, and Milling down 4%. While the company is undergoing significant strategic realignment, including the recent acquisition of Viterra and the divestiture of its U.S. corn milling business, its maintained full-year adjusted EPS guidance of $7.75 already implies a 15.7% annual decline and, critically, excludes any impact from the Viterra integration. The company's balance sheet reflects this activity, with long-term debt increasing to $7.0 billion from $4.7 billion. The stock's 33.4% decline over the past year, underperforming the industry's 20.9% fall, indicates that the market is pricing in these operational challenges and execution risks.

Key Decisions for Investors

• Investors should prioritize monitoring disclosures on the Viterra acquisition's integration and expected synergies, as the current 2025 guidance of $7.75 adjusted EPS explicitly excludes its impact, making the forecast an incomplete basis for valuation.
• Despite the headline earnings beat, the sharp year-over-year declines in adjusted profit and margins across all primary segments signal persistent operational headwinds, warranting a cautious stance on the company's near-term organic growth prospects.
• Given the stock's significant underperformance relative to its industry, it may be prudent to assess whether the current valuation adequately reflects the execution risks of the Viterra merger and the challenging outlook for the broader agriculture sector.